The global crisis of drug-resistant tuberculosis and leadership of China and the BRICS :: challenges and opportunities : summary of a joint workshop by the Institute of Medicine and the Institute of Microbiology, Chinese Academy of Sciences /
Multidrug-resistant tuberculosis (TB) is caused by bacteria resistant to isoniazid and rifampicin, the two most effective first-line anti-TB drugs, originally developed and introduced in the 1950 and 1960s. Since 2008, the Forum on Drug Discovery, Development, and Translation of the Institute of Med...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Körperschaft: | |
| Format: | Elektronisch Tagungsbericht E-Book |
| Sprache: | English |
| Veröffentlicht: |
Washington, D.C. :
The National Academies Press,
[2014]
|
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Zusammenfassung: | Multidrug-resistant tuberculosis (TB) is caused by bacteria resistant to isoniazid and rifampicin, the two most effective first-line anti-TB drugs, originally developed and introduced in the 1950 and 1960s. Since 2008, the Forum on Drug Discovery, Development, and Translation of the Institute of Medicine has hosted or co-hosted six domestic and international workshops addressing the global crisis of drug-resistant TB, with special attention to the BRICS countries - Brazil, Russia, India, China, and South Africa. The Global Crisis of Drug-Resistant Tuberculosis and Leadership of China and the BRICS is the summary of a workshop convened to address the current status of drug-resistant TB globally and in China. This report considers lessons learned from high burden countries; highlights global challenges to controlling the spread of drug-resistant strains; and discusses innovative strategies to advance and harmonize local and international efforts to prevent and treat drug-resistant TB. Additionally, the report examines the problem of MDR TB and emergent TB strains that are potentially untreatable with drugs available and considers the critical leadership role of the BRICS countries in addressing the threats and opportunities in drug-resistant TB. |
| Beschreibung: | Title from PDF title page. |
| Beschreibung: | 1 online resource (1 PDF file (xxi, 195 pages)) : illustrations |
| Bibliographie: | Includes bibliographical references. |
| ISBN: | 9780309285964 0309285968 9780309285971 0309285976 |
Internformat
MARC
| LEADER | 00000cam a2200000 i 4500 | ||
|---|---|---|---|
| 001 | ZDB-4-EBA-ocn870331213 | ||
| 003 | OCoLC | ||
| 005 | 20240705115654.0 | ||
| 006 | m o d | ||
| 007 | cr un||||||||| | ||
| 008 | 140516s2014 dcua obt 100 0 eng | ||
| 040 | |a NLM |b eng |e rda |e pn |c NLM |d COO |d LTSCA |d YDXCP |d E7B |d VT2 |d COP |d MMU |d UCNAP |d N$T |d EBLCP |d DEBSZ |d OCLCO |d D6H |d OCLCA |d OCLCQ |d OCLCO |d COCUF |d MOR |d ZCU |d MERUC |d OCLCQ |d OCLCA |d OCLCO |d OCLCA |d U3W |d OCLCA |d OCLCF |d STF |d VTS |d EZ9 |d ICG |d OCLCQ |d OCLCO |d NLM |d LVT |d TKN |d DKC |d OCLCO |d AU@ |d OCLCQ |d OCLCO |d OCLCQ |d K6U |d OCLCA |d UKAHL |d OCLCO |d OCLCQ |d OCL |d OCLCO |d OCLCL | ||
| 016 | 7 | |a 101633144 |2 DNLM | |
| 019 | |a 871260167 |a 923287859 |a 971083063 |a 1021272863 |a 1061003944 |a 1061062305 |a 1077380361 |a 1081271153 |a 1156332799 |a 1228550393 |a 1249253375 | ||
| 020 | |a 9780309285964 | ||
| 020 | |a 0309285968 | ||
| 020 | |a 9780309285971 | ||
| 020 | |a 0309285976 | ||
| 035 | |a (OCoLC)870331213 |z (OCoLC)871260167 |z (OCoLC)923287859 |z (OCoLC)971083063 |z (OCoLC)1021272863 |z (OCoLC)1061003944 |z (OCoLC)1061062305 |z (OCoLC)1077380361 |z (OCoLC)1081271153 |z (OCoLC)1156332799 |z (OCoLC)1228550393 |z (OCoLC)1249253375 | ||
| 042 | |a pcc | ||
| 043 | |a a-cc--- | ||
| 050 | 4 | |a RC311.1 |b .G56 2014 | |
| 060 | 0 | 0 | |a 2014 I-005 |
| 060 | 0 | 0 | |a WF 200 |
| 072 | 7 | |a POL |x 027000 |2 bisacsh | |
| 072 | 7 | |a POL |x 019000 |2 bisacsh | |
| 082 | 7 | |a 362.19699/5 |2 23 | |
| 049 | |a MAIN | ||
| 100 | 1 | |a Olson, Steve, |d 1956- |e author. |0 http://id.loc.gov/authorities/names/n85025654 | |
| 245 | 1 | 4 | |a The global crisis of drug-resistant tuberculosis and leadership of China and the BRICS : |b challenges and opportunities : summary of a joint workshop by the Institute of Medicine and the Institute of Microbiology, Chinese Academy of Sciences / |c Steve Olson, Rebecca A. English, and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies. |
| 264 | 1 | |a Washington, D.C. : |b The National Academies Press, |c [2014] | |
| 300 | |a 1 online resource (1 PDF file (xxi, 195 pages)) : |b illustrations | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 500 | |a Title from PDF title page. | ||
| 504 | |a Includes bibliographical references. | ||
| 520 | 3 | |a Multidrug-resistant tuberculosis (TB) is caused by bacteria resistant to isoniazid and rifampicin, the two most effective first-line anti-TB drugs, originally developed and introduced in the 1950 and 1960s. Since 2008, the Forum on Drug Discovery, Development, and Translation of the Institute of Medicine has hosted or co-hosted six domestic and international workshops addressing the global crisis of drug-resistant TB, with special attention to the BRICS countries - Brazil, Russia, India, China, and South Africa. The Global Crisis of Drug-Resistant Tuberculosis and Leadership of China and the BRICS is the summary of a workshop convened to address the current status of drug-resistant TB globally and in China. This report considers lessons learned from high burden countries; highlights global challenges to controlling the spread of drug-resistant strains; and discusses innovative strategies to advance and harmonize local and international efforts to prevent and treat drug-resistant TB. Additionally, the report examines the problem of MDR TB and emergent TB strains that are potentially untreatable with drugs available and considers the critical leadership role of the BRICS countries in addressing the threats and opportunities in drug-resistant TB. | |
| 536 | |a This activity was supported by contracts between the National Academy of Sciences and Department of Health and Human Services (HHSN26300023 [Under Base #HHSN263201200074I] and Contract No. N01-OD-4-2139 TO #276; HHSF22301026T [Under Base #HHSF223200810020I]), AbbVie Inc., American Diabetes Association, American Society for Microbiology, Amgen Inc., Association of American Medical Colleges, AstraZeneca, Bristol-Myers Squibb, Burroughs Wellcome Fund, CDC Foundation, Celtic Therapeutics, LLLP, Critical Path Institute, Doris Duke Charitable Foundation, Eli Lilly & Co. Foundation, Eli Lilly and Company, FasterCures, Fondation Merieux, Friends of Cancer Research, GlaxoSmithKline, Johnson & Johnson, March of Dimes Foundation, Merck & Co., Inc., Novartis Pharmaceuticals Corporation, Pfizer Inc., and Sanofi. The views presented in this publication do not necessarily reflect the views of the organizations or agencies that provided support for the activity. | ||
| 588 | 0 | |a Version viewed June 30, 2014. | |
| 505 | 0 | |a The challenges and opportunities for the BRICS countries to lead -- Catching up with the microbe -- Drug-resistant TB in China -- Experiences with MDR TB in other countries -- Drug-resistant tuberculosis in pediatric populations -- Global perspectives on transmission and infection control -- Rapid diagnostic technologies : status and limitations -- Addressing diagnosis and treatment across the spectrum of drug resistance -- Developing and strengthening the drug supply chain for drug-resistant TB -- Embracing a new vision for research -- What will be required to achive zero deaths from TB? -- Creating an evidence-based blueprint for action. | |
| 650 | 0 | |a Multidrug-resistant tuberculosis |v Congresses. | |
| 650 | 0 | |a Multidrug-resistant tuberculosis |x Prevention |v Congresses. | |
| 650 | 0 | |a Tuberculosis |v Congresses. | |
| 650 | 0 | |a Drug resistance |v Congresses. | |
| 650 | 0 | |a Multidrug-resistant tuberculosis. |0 http://id.loc.gov/authorities/subjects/sh2007003767 | |
| 650 | 0 | |a Antitubercular agents. |0 http://id.loc.gov/authorities/subjects/sh85005784 | |
| 650 | 0 | |a World health. |0 http://id.loc.gov/authorities/subjects/sh85148199 | |
| 650 | 0 | |a International cooperation. |0 http://id.loc.gov/authorities/subjects/sh85067385 | |
| 650 | 1 | 2 | |a Tuberculosis, Multidrug-Resistant |0 https://id.nlm.nih.gov/mesh/D018088 |
| 650 | 2 | 2 | |a Antitubercular Agents |0 https://id.nlm.nih.gov/mesh/D000995 |
| 650 | 2 | 2 | |a Global Health |0 https://id.nlm.nih.gov/mesh/D014943 |
| 650 | 2 | 2 | |a International Cooperation |0 https://id.nlm.nih.gov/mesh/D007391 |
| 651 | 2 | |a China |0 https://id.nlm.nih.gov/mesh/D002681 | |
| 650 | 6 | |a Tuberculose multirésistante |v Congrès. | |
| 650 | 6 | |a Tuberculose |v Congrès. | |
| 650 | 6 | |a Résistance aux médicaments |v Congrès. | |
| 650 | 6 | |a Tuberculose multirésistante. | |
| 650 | 6 | |a Antituberculeux. | |
| 650 | 6 | |a Santé mondiale. | |
| 650 | 6 | |a Coopération internationale. | |
| 650 | 7 | |a POLITICAL SCIENCE |x Public Policy |x Social Security. |2 bisacsh | |
| 650 | 7 | |a POLITICAL SCIENCE |x Public Policy |x Social Services & Welfare. |2 bisacsh | |
| 650 | 7 | |a World health |2 fast | |
| 650 | 7 | |a International cooperation |2 fast | |
| 650 | 7 | |a Antitubercular agents |2 fast | |
| 650 | 7 | |a Drug resistance |2 fast | |
| 650 | 7 | |a Multidrug-resistant tuberculosis |2 fast | |
| 650 | 7 | |a Tuberculosis |2 fast | |
| 655 | 2 | |a Congress |0 https://id.nlm.nih.gov/mesh/D016423 | |
| 655 | 7 | |a proceedings (reports) |2 aat | |
| 655 | 7 | |a Conference papers and proceedings |2 fast | |
| 655 | 7 | |a Conference papers and proceedings. |2 lcgft |0 http://id.loc.gov/authorities/genreForms/gf2014026068 | |
| 655 | 7 | |a Actes de congrès. |2 rvmgf | |
| 700 | 1 | |a English, Rebecca A., |e author. | |
| 700 | 1 | |a Claiborne, Anne B., |e author. | |
| 710 | 2 | |a Institute of Medicine (U.S.). |b Forum on Drug Discovery, Development, and Translation, |e issuing body. |0 http://id.loc.gov/authorities/names/no2007051854 | |
| 710 | 2 | |a Institute of Medicine (U.S.), |e sponsoring body. |0 http://id.loc.gov/authorities/names/n79129181 | |
| 710 | 2 | |a Zhongguo ke xue yuan. |b Wei sheng wu yan jiu suo, |e sponsoring body. |0 http://id.loc.gov/authorities/names/n81058995 | |
| 711 | 2 | |a Global Crisis of Drug-Resistant Tuberculosis and Leadership of the BRICS Countries : Challenges and Opportunities (Workshop) |d (2013 : |c Beijing, China) |0 http://id.loc.gov/authorities/names/no2014036486 | |
| 758 | |i has work: |a The global crisis of drug-resistant tuberculosis and leadership of China and the BRICS (Text) |1 https://id.oclc.org/worldcat/entity/E39PCGdjBGJjtrxyhPdjPMWwwd |4 https://id.oclc.org/worldcat/ontology/hasWork | ||
| 776 | 0 | 8 | |i Print version: |a Global Crisis of Drug-Resistant Tuberculosis and Leadership of the BRICS Countries : Challenges and Opportunities (Workshop) (2013 : Beijing, China). |t Global crisis of drug-resistant tuberculosis and leadership of China and the BRICS. |d Washington, D.C. : National Academies Press, [2014] |z 9780309285964 |
| 856 | 1 | |l FWS01 |p ZDB-4-EBA |q FWS_PDA_EBA |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=867773 |3 Volltext | |
| 856 | 1 | |l CBO01 |p ZDB-4-EBA |q FWS_PDA_EBA |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=867773 |3 Volltext | |
| 938 | |a Askews and Holts Library Services |b ASKH |n AH36561400 | ||
| 938 | |a Askews and Holts Library Services |b ASKH |n AH36617758 | ||
| 938 | |a ProQuest Ebook Central |b EBLB |n EBL3379093 | ||
| 938 | |a ebrary |b EBRY |n ebr10863741 | ||
| 938 | |a EBSCOhost |b EBSC |n 867773 | ||
| 938 | |a YBP Library Services |b YANK |n 11575900 | ||
| 938 | |a YBP Library Services |b YANK |n 11864833 | ||
| 994 | |a 92 |b GEBAY | ||
| 912 | |a ZDB-4-EBA | ||
Datensatz im Suchindex
| DE-BY-FWS_katkey | ZDB-4-EBA-ocn870331213 |
|---|---|
| _version_ | 1813903635978911744 |
| adam_text | |
| any_adam_object | |
| author | Olson, Steve, 1956- English, Rebecca A. Claiborne, Anne B. |
| author_GND | http://id.loc.gov/authorities/names/n85025654 |
| author_corporate | Global Crisis of Drug-Resistant Tuberculosis and Leadership of the BRICS Countries : Challenges and Opportunities (Workshop) |
| author_corporate_role | |
| author_facet | Olson, Steve, 1956- English, Rebecca A. Claiborne, Anne B. Global Crisis of Drug-Resistant Tuberculosis and Leadership of the BRICS Countries : Challenges and Opportunities (Workshop) |
| author_role | aut aut aut |
| author_sort | Olson, Steve, 1956- |
| author_variant | s o so r a e ra rae a b c ab abc |
| building | Verbundindex |
| bvnumber | localFWS |
| callnumber-first | R - Medicine |
| callnumber-label | RC311 |
| callnumber-raw | RC311.1 .G56 2014 |
| callnumber-search | RC311.1 .G56 2014 |
| callnumber-sort | RC 3311.1 G56 42014 |
| callnumber-subject | RC - Internal Medicine |
| collection | ZDB-4-EBA |
| contents | The challenges and opportunities for the BRICS countries to lead -- Catching up with the microbe -- Drug-resistant TB in China -- Experiences with MDR TB in other countries -- Drug-resistant tuberculosis in pediatric populations -- Global perspectives on transmission and infection control -- Rapid diagnostic technologies : status and limitations -- Addressing diagnosis and treatment across the spectrum of drug resistance -- Developing and strengthening the drug supply chain for drug-resistant TB -- Embracing a new vision for research -- What will be required to achive zero deaths from TB? -- Creating an evidence-based blueprint for action. |
| ctrlnum | (OCoLC)870331213 |
| dewey-full | 362.19699/5 |
| dewey-hundreds | 300 - Social sciences |
| dewey-ones | 362 - Social problems and services to groups |
| dewey-raw | 362.19699/5 |
| dewey-search | 362.19699/5 |
| dewey-sort | 3362.19699 15 |
| dewey-tens | 360 - Social problems and services; associations |
| discipline | Soziologie |
| format | Electronic Conference Proceeding eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>09040cam a2201057 i 4500</leader><controlfield tag="001">ZDB-4-EBA-ocn870331213</controlfield><controlfield tag="003">OCoLC</controlfield><controlfield tag="005">20240705115654.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr un|||||||||</controlfield><controlfield tag="008">140516s2014 dcua obt 100 0 eng </controlfield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NLM</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="e">pn</subfield><subfield code="c">NLM</subfield><subfield code="d">COO</subfield><subfield code="d">LTSCA</subfield><subfield code="d">YDXCP</subfield><subfield code="d">E7B</subfield><subfield code="d">VT2</subfield><subfield code="d">COP</subfield><subfield code="d">MMU</subfield><subfield code="d">UCNAP</subfield><subfield code="d">N$T</subfield><subfield code="d">EBLCP</subfield><subfield code="d">DEBSZ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">D6H</subfield><subfield code="d">OCLCA</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">COCUF</subfield><subfield code="d">MOR</subfield><subfield code="d">ZCU</subfield><subfield code="d">MERUC</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCA</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCA</subfield><subfield code="d">U3W</subfield><subfield code="d">OCLCA</subfield><subfield code="d">OCLCF</subfield><subfield code="d">STF</subfield><subfield code="d">VTS</subfield><subfield code="d">EZ9</subfield><subfield code="d">ICG</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">NLM</subfield><subfield code="d">LVT</subfield><subfield code="d">TKN</subfield><subfield code="d">DKC</subfield><subfield code="d">OCLCO</subfield><subfield code="d">AU@</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">K6U</subfield><subfield code="d">OCLCA</subfield><subfield code="d">UKAHL</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCL</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCL</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">101633144</subfield><subfield code="2">DNLM</subfield></datafield><datafield tag="019" ind1=" " ind2=" "><subfield code="a">871260167</subfield><subfield code="a">923287859</subfield><subfield code="a">971083063</subfield><subfield code="a">1021272863</subfield><subfield code="a">1061003944</subfield><subfield code="a">1061062305</subfield><subfield code="a">1077380361</subfield><subfield code="a">1081271153</subfield><subfield code="a">1156332799</subfield><subfield code="a">1228550393</subfield><subfield code="a">1249253375</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780309285964</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0309285968</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780309285971</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0309285976</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)870331213</subfield><subfield code="z">(OCoLC)871260167</subfield><subfield code="z">(OCoLC)923287859</subfield><subfield code="z">(OCoLC)971083063</subfield><subfield code="z">(OCoLC)1021272863</subfield><subfield code="z">(OCoLC)1061003944</subfield><subfield code="z">(OCoLC)1061062305</subfield><subfield code="z">(OCoLC)1077380361</subfield><subfield code="z">(OCoLC)1081271153</subfield><subfield code="z">(OCoLC)1156332799</subfield><subfield code="z">(OCoLC)1228550393</subfield><subfield code="z">(OCoLC)1249253375</subfield></datafield><datafield tag="042" ind1=" " ind2=" "><subfield code="a">pcc</subfield></datafield><datafield tag="043" ind1=" " ind2=" "><subfield code="a">a-cc---</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RC311.1</subfield><subfield code="b">.G56 2014</subfield></datafield><datafield tag="060" ind1="0" ind2="0"><subfield code="a">2014 I-005</subfield></datafield><datafield tag="060" ind1="0" ind2="0"><subfield code="a">WF 200</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">POL</subfield><subfield code="x">027000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">POL</subfield><subfield code="x">019000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="082" ind1="7" ind2=" "><subfield code="a">362.19699/5</subfield><subfield code="2">23</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">MAIN</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Olson, Steve,</subfield><subfield code="d">1956-</subfield><subfield code="e">author.</subfield><subfield code="0">http://id.loc.gov/authorities/names/n85025654</subfield></datafield><datafield tag="245" ind1="1" ind2="4"><subfield code="a">The global crisis of drug-resistant tuberculosis and leadership of China and the BRICS :</subfield><subfield code="b">challenges and opportunities : summary of a joint workshop by the Institute of Medicine and the Institute of Microbiology, Chinese Academy of Sciences /</subfield><subfield code="c">Steve Olson, Rebecca A. English, and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Washington, D.C. :</subfield><subfield code="b">The National Academies Press,</subfield><subfield code="c">[2014]</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (1 PDF file (xxi, 195 pages)) :</subfield><subfield code="b">illustrations</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Title from PDF title page.</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references.</subfield></datafield><datafield tag="520" ind1="3" ind2=" "><subfield code="a">Multidrug-resistant tuberculosis (TB) is caused by bacteria resistant to isoniazid and rifampicin, the two most effective first-line anti-TB drugs, originally developed and introduced in the 1950 and 1960s. Since 2008, the Forum on Drug Discovery, Development, and Translation of the Institute of Medicine has hosted or co-hosted six domestic and international workshops addressing the global crisis of drug-resistant TB, with special attention to the BRICS countries - Brazil, Russia, India, China, and South Africa. The Global Crisis of Drug-Resistant Tuberculosis and Leadership of China and the BRICS is the summary of a workshop convened to address the current status of drug-resistant TB globally and in China. This report considers lessons learned from high burden countries; highlights global challenges to controlling the spread of drug-resistant strains; and discusses innovative strategies to advance and harmonize local and international efforts to prevent and treat drug-resistant TB. Additionally, the report examines the problem of MDR TB and emergent TB strains that are potentially untreatable with drugs available and considers the critical leadership role of the BRICS countries in addressing the threats and opportunities in drug-resistant TB.</subfield></datafield><datafield tag="536" ind1=" " ind2=" "><subfield code="a">This activity was supported by contracts between the National Academy of Sciences and Department of Health and Human Services (HHSN26300023 [Under Base #HHSN263201200074I] and Contract No. N01-OD-4-2139 TO #276; HHSF22301026T [Under Base #HHSF223200810020I]), AbbVie Inc., American Diabetes Association, American Society for Microbiology, Amgen Inc., Association of American Medical Colleges, AstraZeneca, Bristol-Myers Squibb, Burroughs Wellcome Fund, CDC Foundation, Celtic Therapeutics, LLLP, Critical Path Institute, Doris Duke Charitable Foundation, Eli Lilly & Co. Foundation, Eli Lilly and Company, FasterCures, Fondation Merieux, Friends of Cancer Research, GlaxoSmithKline, Johnson & Johnson, March of Dimes Foundation, Merck & Co., Inc., Novartis Pharmaceuticals Corporation, Pfizer Inc., and Sanofi. The views presented in this publication do not necessarily reflect the views of the organizations or agencies that provided support for the activity.</subfield></datafield><datafield tag="588" ind1="0" ind2=" "><subfield code="a">Version viewed June 30, 2014.</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">The challenges and opportunities for the BRICS countries to lead -- Catching up with the microbe -- Drug-resistant TB in China -- Experiences with MDR TB in other countries -- Drug-resistant tuberculosis in pediatric populations -- Global perspectives on transmission and infection control -- Rapid diagnostic technologies : status and limitations -- Addressing diagnosis and treatment across the spectrum of drug resistance -- Developing and strengthening the drug supply chain for drug-resistant TB -- Embracing a new vision for research -- What will be required to achive zero deaths from TB? -- Creating an evidence-based blueprint for action.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Multidrug-resistant tuberculosis</subfield><subfield code="v">Congresses.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Multidrug-resistant tuberculosis</subfield><subfield code="x">Prevention</subfield><subfield code="v">Congresses.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Tuberculosis</subfield><subfield code="v">Congresses.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Drug resistance</subfield><subfield code="v">Congresses.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Multidrug-resistant tuberculosis.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh2007003767</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Antitubercular agents.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85005784</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">World health.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85148199</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">International cooperation.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85067385</subfield></datafield><datafield tag="650" ind1="1" ind2="2"><subfield code="a">Tuberculosis, Multidrug-Resistant</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D018088</subfield></datafield><datafield tag="650" ind1="2" ind2="2"><subfield code="a">Antitubercular Agents</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D000995</subfield></datafield><datafield tag="650" ind1="2" ind2="2"><subfield code="a">Global Health</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D014943</subfield></datafield><datafield tag="650" ind1="2" ind2="2"><subfield code="a">International Cooperation</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D007391</subfield></datafield><datafield tag="651" ind1=" " ind2="2"><subfield code="a">China</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D002681</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Tuberculose multirésistante</subfield><subfield code="v">Congrès.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Tuberculose</subfield><subfield code="v">Congrès.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Résistance aux médicaments</subfield><subfield code="v">Congrès.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Tuberculose multirésistante.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Antituberculeux.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Santé mondiale.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Coopération internationale.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">POLITICAL SCIENCE</subfield><subfield code="x">Public Policy</subfield><subfield code="x">Social Security.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">POLITICAL SCIENCE</subfield><subfield code="x">Public Policy</subfield><subfield code="x">Social Services & Welfare.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">World health</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">International cooperation</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Antitubercular agents</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Drug resistance</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Multidrug-resistant tuberculosis</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Tuberculosis</subfield><subfield code="2">fast</subfield></datafield><datafield tag="655" ind1=" " ind2="2"><subfield code="a">Congress</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D016423</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="a">proceedings (reports)</subfield><subfield code="2">aat</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="a">Conference papers and proceedings</subfield><subfield code="2">fast</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="a">Conference papers and proceedings.</subfield><subfield code="2">lcgft</subfield><subfield code="0">http://id.loc.gov/authorities/genreForms/gf2014026068</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="a">Actes de congrès.</subfield><subfield code="2">rvmgf</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">English, Rebecca A.,</subfield><subfield code="e">author.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Claiborne, Anne B.,</subfield><subfield code="e">author.</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">Institute of Medicine (U.S.).</subfield><subfield code="b">Forum on Drug Discovery, Development, and Translation,</subfield><subfield code="e">issuing body.</subfield><subfield code="0">http://id.loc.gov/authorities/names/no2007051854</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">Institute of Medicine (U.S.),</subfield><subfield code="e">sponsoring body.</subfield><subfield code="0">http://id.loc.gov/authorities/names/n79129181</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">Zhongguo ke xue yuan.</subfield><subfield code="b">Wei sheng wu yan jiu suo,</subfield><subfield code="e">sponsoring body.</subfield><subfield code="0">http://id.loc.gov/authorities/names/n81058995</subfield></datafield><datafield tag="711" ind1="2" ind2=" "><subfield code="a">Global Crisis of Drug-Resistant Tuberculosis and Leadership of the BRICS Countries : Challenges and Opportunities (Workshop)</subfield><subfield code="d">(2013 :</subfield><subfield code="c">Beijing, China)</subfield><subfield code="0">http://id.loc.gov/authorities/names/no2014036486</subfield></datafield><datafield tag="758" ind1=" " ind2=" "><subfield code="i">has work:</subfield><subfield code="a">The global crisis of drug-resistant tuberculosis and leadership of China and the BRICS (Text)</subfield><subfield code="1">https://id.oclc.org/worldcat/entity/E39PCGdjBGJjtrxyhPdjPMWwwd</subfield><subfield code="4">https://id.oclc.org/worldcat/ontology/hasWork</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Print version:</subfield><subfield code="a">Global Crisis of Drug-Resistant Tuberculosis and Leadership of the BRICS Countries : Challenges and Opportunities (Workshop) (2013 : Beijing, China).</subfield><subfield code="t">Global crisis of drug-resistant tuberculosis and leadership of China and the BRICS.</subfield><subfield code="d">Washington, D.C. : National Academies Press, [2014]</subfield><subfield code="z">9780309285964</subfield></datafield><datafield tag="856" ind1="1" ind2=" "><subfield code="l">FWS01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=867773</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="1" ind2=" "><subfield code="l">CBO01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=867773</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">Askews and Holts Library Services</subfield><subfield code="b">ASKH</subfield><subfield code="n">AH36561400</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">Askews and Holts Library Services</subfield><subfield code="b">ASKH</subfield><subfield code="n">AH36617758</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ProQuest Ebook Central</subfield><subfield code="b">EBLB</subfield><subfield code="n">EBL3379093</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ebrary</subfield><subfield code="b">EBRY</subfield><subfield code="n">ebr10863741</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBSCOhost</subfield><subfield code="b">EBSC</subfield><subfield code="n">867773</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">YBP Library Services</subfield><subfield code="b">YANK</subfield><subfield code="n">11575900</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">YBP Library Services</subfield><subfield code="b">YANK</subfield><subfield code="n">11864833</subfield></datafield><datafield tag="994" ind1=" " ind2=" "><subfield code="a">92</subfield><subfield code="b">GEBAY</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield></record></collection> |
| genre | Congress https://id.nlm.nih.gov/mesh/D016423 proceedings (reports) aat Conference papers and proceedings fast Conference papers and proceedings. lcgft http://id.loc.gov/authorities/genreForms/gf2014026068 Actes de congrès. rvmgf |
| genre_facet | Congress proceedings (reports) Conference papers and proceedings Conference papers and proceedings. Actes de congrès. |
| geographic | China https://id.nlm.nih.gov/mesh/D002681 |
| geographic_facet | China |
| id | ZDB-4-EBA-ocn870331213 |
| illustrated | Illustrated |
| indexdate | 2024-10-25T16:21:49Z |
| institution | BVB |
| institution_GND | http://id.loc.gov/authorities/names/no2007051854 http://id.loc.gov/authorities/names/n79129181 http://id.loc.gov/authorities/names/n81058995 http://id.loc.gov/authorities/names/no2014036486 |
| isbn | 9780309285964 0309285968 9780309285971 0309285976 |
| language | English |
| oclc_num | 870331213 |
| open_access_boolean | |
| owner | MAIN |
| owner_facet | MAIN |
| physical | 1 online resource (1 PDF file (xxi, 195 pages)) : illustrations |
| psigel | ZDB-4-EBA |
| publishDate | 2014 |
| publishDateSearch | 2014 |
| publishDateSort | 2014 |
| publisher | The National Academies Press, |
| record_format | marc |
| spelling | Olson, Steve, 1956- author. http://id.loc.gov/authorities/names/n85025654 The global crisis of drug-resistant tuberculosis and leadership of China and the BRICS : challenges and opportunities : summary of a joint workshop by the Institute of Medicine and the Institute of Microbiology, Chinese Academy of Sciences / Steve Olson, Rebecca A. English, and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies. Washington, D.C. : The National Academies Press, [2014] 1 online resource (1 PDF file (xxi, 195 pages)) : illustrations text txt rdacontent computer c rdamedia online resource cr rdacarrier Title from PDF title page. Includes bibliographical references. Multidrug-resistant tuberculosis (TB) is caused by bacteria resistant to isoniazid and rifampicin, the two most effective first-line anti-TB drugs, originally developed and introduced in the 1950 and 1960s. Since 2008, the Forum on Drug Discovery, Development, and Translation of the Institute of Medicine has hosted or co-hosted six domestic and international workshops addressing the global crisis of drug-resistant TB, with special attention to the BRICS countries - Brazil, Russia, India, China, and South Africa. The Global Crisis of Drug-Resistant Tuberculosis and Leadership of China and the BRICS is the summary of a workshop convened to address the current status of drug-resistant TB globally and in China. This report considers lessons learned from high burden countries; highlights global challenges to controlling the spread of drug-resistant strains; and discusses innovative strategies to advance and harmonize local and international efforts to prevent and treat drug-resistant TB. Additionally, the report examines the problem of MDR TB and emergent TB strains that are potentially untreatable with drugs available and considers the critical leadership role of the BRICS countries in addressing the threats and opportunities in drug-resistant TB. This activity was supported by contracts between the National Academy of Sciences and Department of Health and Human Services (HHSN26300023 [Under Base #HHSN263201200074I] and Contract No. N01-OD-4-2139 TO #276; HHSF22301026T [Under Base #HHSF223200810020I]), AbbVie Inc., American Diabetes Association, American Society for Microbiology, Amgen Inc., Association of American Medical Colleges, AstraZeneca, Bristol-Myers Squibb, Burroughs Wellcome Fund, CDC Foundation, Celtic Therapeutics, LLLP, Critical Path Institute, Doris Duke Charitable Foundation, Eli Lilly & Co. Foundation, Eli Lilly and Company, FasterCures, Fondation Merieux, Friends of Cancer Research, GlaxoSmithKline, Johnson & Johnson, March of Dimes Foundation, Merck & Co., Inc., Novartis Pharmaceuticals Corporation, Pfizer Inc., and Sanofi. The views presented in this publication do not necessarily reflect the views of the organizations or agencies that provided support for the activity. Version viewed June 30, 2014. The challenges and opportunities for the BRICS countries to lead -- Catching up with the microbe -- Drug-resistant TB in China -- Experiences with MDR TB in other countries -- Drug-resistant tuberculosis in pediatric populations -- Global perspectives on transmission and infection control -- Rapid diagnostic technologies : status and limitations -- Addressing diagnosis and treatment across the spectrum of drug resistance -- Developing and strengthening the drug supply chain for drug-resistant TB -- Embracing a new vision for research -- What will be required to achive zero deaths from TB? -- Creating an evidence-based blueprint for action. Multidrug-resistant tuberculosis Congresses. Multidrug-resistant tuberculosis Prevention Congresses. Tuberculosis Congresses. Drug resistance Congresses. Multidrug-resistant tuberculosis. http://id.loc.gov/authorities/subjects/sh2007003767 Antitubercular agents. http://id.loc.gov/authorities/subjects/sh85005784 World health. http://id.loc.gov/authorities/subjects/sh85148199 International cooperation. http://id.loc.gov/authorities/subjects/sh85067385 Tuberculosis, Multidrug-Resistant https://id.nlm.nih.gov/mesh/D018088 Antitubercular Agents https://id.nlm.nih.gov/mesh/D000995 Global Health https://id.nlm.nih.gov/mesh/D014943 International Cooperation https://id.nlm.nih.gov/mesh/D007391 China https://id.nlm.nih.gov/mesh/D002681 Tuberculose multirésistante Congrès. Tuberculose Congrès. Résistance aux médicaments Congrès. Tuberculose multirésistante. Antituberculeux. Santé mondiale. Coopération internationale. POLITICAL SCIENCE Public Policy Social Security. bisacsh POLITICAL SCIENCE Public Policy Social Services & Welfare. bisacsh World health fast International cooperation fast Antitubercular agents fast Drug resistance fast Multidrug-resistant tuberculosis fast Tuberculosis fast Congress https://id.nlm.nih.gov/mesh/D016423 proceedings (reports) aat Conference papers and proceedings fast Conference papers and proceedings. lcgft http://id.loc.gov/authorities/genreForms/gf2014026068 Actes de congrès. rvmgf English, Rebecca A., author. Claiborne, Anne B., author. Institute of Medicine (U.S.). Forum on Drug Discovery, Development, and Translation, issuing body. http://id.loc.gov/authorities/names/no2007051854 Institute of Medicine (U.S.), sponsoring body. http://id.loc.gov/authorities/names/n79129181 Zhongguo ke xue yuan. Wei sheng wu yan jiu suo, sponsoring body. http://id.loc.gov/authorities/names/n81058995 Global Crisis of Drug-Resistant Tuberculosis and Leadership of the BRICS Countries : Challenges and Opportunities (Workshop) (2013 : Beijing, China) http://id.loc.gov/authorities/names/no2014036486 has work: The global crisis of drug-resistant tuberculosis and leadership of China and the BRICS (Text) https://id.oclc.org/worldcat/entity/E39PCGdjBGJjtrxyhPdjPMWwwd https://id.oclc.org/worldcat/ontology/hasWork Print version: Global Crisis of Drug-Resistant Tuberculosis and Leadership of the BRICS Countries : Challenges and Opportunities (Workshop) (2013 : Beijing, China). Global crisis of drug-resistant tuberculosis and leadership of China and the BRICS. Washington, D.C. : National Academies Press, [2014] 9780309285964 FWS01 ZDB-4-EBA FWS_PDA_EBA https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=867773 Volltext CBO01 ZDB-4-EBA FWS_PDA_EBA https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=867773 Volltext |
| spellingShingle | Olson, Steve, 1956- English, Rebecca A. Claiborne, Anne B. The global crisis of drug-resistant tuberculosis and leadership of China and the BRICS : challenges and opportunities : summary of a joint workshop by the Institute of Medicine and the Institute of Microbiology, Chinese Academy of Sciences / The challenges and opportunities for the BRICS countries to lead -- Catching up with the microbe -- Drug-resistant TB in China -- Experiences with MDR TB in other countries -- Drug-resistant tuberculosis in pediatric populations -- Global perspectives on transmission and infection control -- Rapid diagnostic technologies : status and limitations -- Addressing diagnosis and treatment across the spectrum of drug resistance -- Developing and strengthening the drug supply chain for drug-resistant TB -- Embracing a new vision for research -- What will be required to achive zero deaths from TB? -- Creating an evidence-based blueprint for action. Multidrug-resistant tuberculosis Congresses. Multidrug-resistant tuberculosis Prevention Congresses. Tuberculosis Congresses. Drug resistance Congresses. Multidrug-resistant tuberculosis. http://id.loc.gov/authorities/subjects/sh2007003767 Antitubercular agents. http://id.loc.gov/authorities/subjects/sh85005784 World health. http://id.loc.gov/authorities/subjects/sh85148199 International cooperation. http://id.loc.gov/authorities/subjects/sh85067385 Tuberculosis, Multidrug-Resistant https://id.nlm.nih.gov/mesh/D018088 Antitubercular Agents https://id.nlm.nih.gov/mesh/D000995 Global Health https://id.nlm.nih.gov/mesh/D014943 International Cooperation https://id.nlm.nih.gov/mesh/D007391 Tuberculose multirésistante Congrès. Tuberculose Congrès. Résistance aux médicaments Congrès. Tuberculose multirésistante. Antituberculeux. Santé mondiale. Coopération internationale. POLITICAL SCIENCE Public Policy Social Security. bisacsh POLITICAL SCIENCE Public Policy Social Services & Welfare. bisacsh World health fast International cooperation fast Antitubercular agents fast Drug resistance fast Multidrug-resistant tuberculosis fast Tuberculosis fast |
| subject_GND | http://id.loc.gov/authorities/subjects/sh2007003767 http://id.loc.gov/authorities/subjects/sh85005784 http://id.loc.gov/authorities/subjects/sh85148199 http://id.loc.gov/authorities/subjects/sh85067385 https://id.nlm.nih.gov/mesh/D018088 https://id.nlm.nih.gov/mesh/D000995 https://id.nlm.nih.gov/mesh/D014943 https://id.nlm.nih.gov/mesh/D007391 https://id.nlm.nih.gov/mesh/D002681 https://id.nlm.nih.gov/mesh/D016423 http://id.loc.gov/authorities/genreForms/gf2014026068 |
| title | The global crisis of drug-resistant tuberculosis and leadership of China and the BRICS : challenges and opportunities : summary of a joint workshop by the Institute of Medicine and the Institute of Microbiology, Chinese Academy of Sciences / |
| title_auth | The global crisis of drug-resistant tuberculosis and leadership of China and the BRICS : challenges and opportunities : summary of a joint workshop by the Institute of Medicine and the Institute of Microbiology, Chinese Academy of Sciences / |
| title_exact_search | The global crisis of drug-resistant tuberculosis and leadership of China and the BRICS : challenges and opportunities : summary of a joint workshop by the Institute of Medicine and the Institute of Microbiology, Chinese Academy of Sciences / |
| title_full | The global crisis of drug-resistant tuberculosis and leadership of China and the BRICS : challenges and opportunities : summary of a joint workshop by the Institute of Medicine and the Institute of Microbiology, Chinese Academy of Sciences / Steve Olson, Rebecca A. English, and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies. |
| title_fullStr | The global crisis of drug-resistant tuberculosis and leadership of China and the BRICS : challenges and opportunities : summary of a joint workshop by the Institute of Medicine and the Institute of Microbiology, Chinese Academy of Sciences / Steve Olson, Rebecca A. English, and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies. |
| title_full_unstemmed | The global crisis of drug-resistant tuberculosis and leadership of China and the BRICS : challenges and opportunities : summary of a joint workshop by the Institute of Medicine and the Institute of Microbiology, Chinese Academy of Sciences / Steve Olson, Rebecca A. English, and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies. |
| title_short | The global crisis of drug-resistant tuberculosis and leadership of China and the BRICS : |
| title_sort | global crisis of drug resistant tuberculosis and leadership of china and the brics challenges and opportunities summary of a joint workshop by the institute of medicine and the institute of microbiology chinese academy of sciences |
| title_sub | challenges and opportunities : summary of a joint workshop by the Institute of Medicine and the Institute of Microbiology, Chinese Academy of Sciences / |
| topic | Multidrug-resistant tuberculosis Congresses. Multidrug-resistant tuberculosis Prevention Congresses. Tuberculosis Congresses. Drug resistance Congresses. Multidrug-resistant tuberculosis. http://id.loc.gov/authorities/subjects/sh2007003767 Antitubercular agents. http://id.loc.gov/authorities/subjects/sh85005784 World health. http://id.loc.gov/authorities/subjects/sh85148199 International cooperation. http://id.loc.gov/authorities/subjects/sh85067385 Tuberculosis, Multidrug-Resistant https://id.nlm.nih.gov/mesh/D018088 Antitubercular Agents https://id.nlm.nih.gov/mesh/D000995 Global Health https://id.nlm.nih.gov/mesh/D014943 International Cooperation https://id.nlm.nih.gov/mesh/D007391 Tuberculose multirésistante Congrès. Tuberculose Congrès. Résistance aux médicaments Congrès. Tuberculose multirésistante. Antituberculeux. Santé mondiale. Coopération internationale. POLITICAL SCIENCE Public Policy Social Security. bisacsh POLITICAL SCIENCE Public Policy Social Services & Welfare. bisacsh World health fast International cooperation fast Antitubercular agents fast Drug resistance fast Multidrug-resistant tuberculosis fast Tuberculosis fast |
| topic_facet | Multidrug-resistant tuberculosis Congresses. Multidrug-resistant tuberculosis Prevention Congresses. Tuberculosis Congresses. Drug resistance Congresses. Multidrug-resistant tuberculosis. Antitubercular agents. World health. International cooperation. Tuberculosis, Multidrug-Resistant Antitubercular Agents Global Health International Cooperation China Tuberculose multirésistante Congrès. Tuberculose Congrès. Résistance aux médicaments Congrès. Tuberculose multirésistante. Antituberculeux. Santé mondiale. Coopération internationale. POLITICAL SCIENCE Public Policy Social Security. POLITICAL SCIENCE Public Policy Social Services & Welfare. World health International cooperation Antitubercular agents Drug resistance Multidrug-resistant tuberculosis Tuberculosis Congress proceedings (reports) Conference papers and proceedings Conference papers and proceedings. Actes de congrès. |
| url | https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=867773 |
| work_keys_str_mv | AT olsonsteve theglobalcrisisofdrugresistanttuberculosisandleadershipofchinaandthebricschallengesandopportunitiessummaryofajointworkshopbytheinstituteofmedicineandtheinstituteofmicrobiologychineseacademyofsciences AT englishrebeccaa theglobalcrisisofdrugresistanttuberculosisandleadershipofchinaandthebricschallengesandopportunitiessummaryofajointworkshopbytheinstituteofmedicineandtheinstituteofmicrobiologychineseacademyofsciences AT claiborneanneb theglobalcrisisofdrugresistanttuberculosisandleadershipofchinaandthebricschallengesandopportunitiessummaryofajointworkshopbytheinstituteofmedicineandtheinstituteofmicrobiologychineseacademyofsciences AT instituteofmedicineusforumondrugdiscoverydevelopmentandtranslation theglobalcrisisofdrugresistanttuberculosisandleadershipofchinaandthebricschallengesandopportunitiessummaryofajointworkshopbytheinstituteofmedicineandtheinstituteofmicrobiologychineseacademyofsciences AT instituteofmedicineus theglobalcrisisofdrugresistanttuberculosisandleadershipofchinaandthebricschallengesandopportunitiessummaryofajointworkshopbytheinstituteofmedicineandtheinstituteofmicrobiologychineseacademyofsciences AT zhongguokexueyuanweishengwuyanjiusuo theglobalcrisisofdrugresistanttuberculosisandleadershipofchinaandthebricschallengesandopportunitiessummaryofajointworkshopbytheinstituteofmedicineandtheinstituteofmicrobiologychineseacademyofsciences AT globalcrisisofdrugresistanttuberculosisandleadershipofthebricscountrieschallengesandopportunitiesworkshopbeijingchina theglobalcrisisofdrugresistanttuberculosisandleadershipofchinaandthebricschallengesandopportunitiessummaryofajointworkshopbytheinstituteofmedicineandtheinstituteofmicrobiologychineseacademyofsciences AT olsonsteve globalcrisisofdrugresistanttuberculosisandleadershipofchinaandthebricschallengesandopportunitiessummaryofajointworkshopbytheinstituteofmedicineandtheinstituteofmicrobiologychineseacademyofsciences AT englishrebeccaa globalcrisisofdrugresistanttuberculosisandleadershipofchinaandthebricschallengesandopportunitiessummaryofajointworkshopbytheinstituteofmedicineandtheinstituteofmicrobiologychineseacademyofsciences AT claiborneanneb globalcrisisofdrugresistanttuberculosisandleadershipofchinaandthebricschallengesandopportunitiessummaryofajointworkshopbytheinstituteofmedicineandtheinstituteofmicrobiologychineseacademyofsciences AT instituteofmedicineusforumondrugdiscoverydevelopmentandtranslation globalcrisisofdrugresistanttuberculosisandleadershipofchinaandthebricschallengesandopportunitiessummaryofajointworkshopbytheinstituteofmedicineandtheinstituteofmicrobiologychineseacademyofsciences AT instituteofmedicineus globalcrisisofdrugresistanttuberculosisandleadershipofchinaandthebricschallengesandopportunitiessummaryofajointworkshopbytheinstituteofmedicineandtheinstituteofmicrobiologychineseacademyofsciences AT zhongguokexueyuanweishengwuyanjiusuo globalcrisisofdrugresistanttuberculosisandleadershipofchinaandthebricschallengesandopportunitiessummaryofajointworkshopbytheinstituteofmedicineandtheinstituteofmicrobiologychineseacademyofsciences AT globalcrisisofdrugresistanttuberculosisandleadershipofthebricscountrieschallengesandopportunitiesworkshopbeijingchina globalcrisisofdrugresistanttuberculosisandleadershipofchinaandthebricschallengesandopportunitiessummaryofajointworkshopbytheinstituteofmedicineandtheinstituteofmicrobiologychineseacademyofsciences |